Upstream Bio (UPB) Revenue (2023 - 2026)
Upstream Bio (UPB) posted quarterly Revenue of $1.0 million for Q1 2026, up 82.69% year-over-year from $566000.0 in Q1 2025, and up 54.79% quarter-over-quarter from $668000.0 in Q4 2025.
Powered by 
Analysis
Upstream Bio (UPB) Revenue (2023 - 2026) Analysis & Trends
Upstream Bio's Revenue history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Revenue rose 82.69% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $3.3 million (up 44.69% YoY), while the FY2025 annual figure was $2.9 million, up 20.42% from the prior year.
- Revenue for Q1 2026 stood at $1.0 million, up from $668000.0 in the prior quarter.
- The five-year high for Revenue was $1.0 million in Q1 2026, with the low at $450000.0 in Q4 2023.
- The 4-year median for Revenue is $621000.0 (2023), against an average of $666272.7.
- Peak annual rise in Revenue reached 83.73% in 2025, while the deepest fall reached 11.56% in 2025.
- Upstream Bio's Revenue stood at $450000.0 in 2023, then surged by 36.22% to $613000.0 in 2024, then climbed by 8.97% to $668000.0 in 2025, then soared by 54.79% to $1.0 million in 2026.
- Business Quant data shows UPB's Revenue at $1.0 million in Q1 2026, $668000.0 in Q4 2025, and $683000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 145.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1.71 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 674.14 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Upstream Bio | 327.95 Mn | 327.95 Mn | -3.29 Mn | 773,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 773,000.00 |
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 668,000.00 |
| Sep 30, 2025 | 683,000.00 |
| Jun 30, 2025 | 937,000.00 |
| Mar 31, 2025 | 566,000.00 |
| Dec 31, 2024 | 613,000.00 |
| Sep 30, 2024 | 607,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 640,000.00 |
| Dec 31, 2023 | 450,000.00 |
| Sep 30, 2023 | 621,000.00 |